Valuation: AstraZeneca PLC

Market Cap 27TCr 23TCr 22TCr 20TCr 38TCr 25,57500Cr 39TCr 2,59700Cr 1,01600Cr 12,65600Cr 1,00200Cr 98TCr 43,75100Cr P/E 2026 *
22x
P/E 2027 * 19.2x
Enterprise Value 29TCr 25TCr 24TCr 22TCr 40TCr 27,49600Cr 41TCr 2,79200Cr 1,09200Cr 13,60600Cr 1,07800Cr 1,05400Cr 47,03700Cr EV / Sales 2026 *
4.54x
EV / Sales 2027 * 4.18x
Free-Float
96.63%
Yield 2026 *
1.93%
Yield 2027 * 2.05%
1 day+1.85%
1 week+2.78%
Current month-8.32%
1 month-7.19%
3 months-8.71%
6 months-5.04%
Current year-9.86%
1 week 43.39
Extreme 43.39
45.41
1 month 42.71
Extreme 42.71
50.6
Current year 42.71
Extreme 42.71
53.8
1 year 36.7
Extreme 36.7
53.8
3 years 29.05
Extreme 29.05
53.8
5 years 28
Extreme 28
53.8
10 years 28
Extreme 28
53.8
Manager TitleAgeSince
Chief Executive Officer 66 01/10/2012
Director of Finance/CFO 52 01/08/2021
Compliance Officer - 01/01/2023
Director TitleAgeSince
Director/Board Member 70 06/04/1999
Director/Board Member 66 01/10/2012
Director/Board Member 65 27/04/2017
Change 5-day change 1-year change 3-year change Capi.($)
+1.85%+2.78% - - 27TCr
-0.19%+4.73%+59.65%+167.97% 1,08900Cr
-0.23%+4.17%+58.40%+58.94% 64TCr
+1.12%+5.22%+39.38%+78.18% 47TCr
-1.69%+8.81%+39.38%+33.67% 36TCr
-0.51%+3.51%+36.97%+42.46% 30TCr
+0.79%+5.81%-2.55%-38.10% 23TCr
-0.95%+6.48%+28.40%+66.46% 21TCr
-0.10%+3.11%+17.65%+76.50% 17TCr
-0.22%+1.51%+3.68%-30.13% 14TCr
Average +0.02%+4.64%+31.22%+50.66% 40.09TCr
Weighted average by Cap. -0.01%+5.04%+42.98%+82.03%

Financials

2026 *2027 *
Net sales 6.33TCr 5.56TCr 5.19TCr 4.76TCr 8.92TCr 6,06200Cr 9.14TCr 62TCr 24TCr 3,00000Cr 24TCr 23TCr 10,37000Cr 6.68TCr 5.87TCr 5.48TCr 5.03TCr 9.42TCr 6,40200Cr 9.65TCr 65TCr 25TCr 3,16800Cr 25TCr 25TCr 10,95200Cr
Net income 1.21TCr 1.06TCr 991.21Cr 909.67Cr 1.7TCr 1,15800Cr 1.74TCr 12TCr 4.6TCr 57TCr 4.54TCr 4.44TCr 1,98000Cr 1.37TCr 1.2TCr 1.12TCr 1.03TCr 1.93TCr 1,31300Cr 1.98TCr 13TCr 5.21TCr 65TCr 5.15TCr 5.04TCr 2,24600Cr
Net Debt 2.01TCr 1.76TCr 1.64TCr 1.51TCr 2.83TCr 1,92100Cr 2.9TCr 20TCr 7.63TCr 95TCr 7.53TCr 7.37TCr 3,28600Cr 1.26TCr 1.1TCr 1.03TCr 945.63Cr 1.77TCr 1,20300Cr 1.81TCr 12TCr 4.78TCr 60TCr 4.72TCr 4.61TCr 2,05800Cr
Logo AstraZeneca PLC
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (99.8%). Net sales break down by treatment area between oncology (42.6%), cardiovascular, renal and metabolic diseases (23%), respiratory and autoimmune diseases (14.7%), and other (19.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (0.2). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (22.9%), the United States (40.8%), Americas (6.1%) and Africa/Asia/Australia (22.8%).
Employees
96,100
Date Price Change Volume
28/26/28 $45.07 +1.85% 48
27/26/27 $44.25 +0.05% 24
24/26/24 $44.23 +1.89% 9
23/26/23 $43.41 -1.34% 4
22/26/22 $44.00 +0.34% 9
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
172.15USD
Average target price
212.36USD
Spread / Average Target
+23.35%

Quarterly revenue - Rate of surprise